ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is soliciting investors who purchased shares of Embecta Corp., Nano-X Imaging Ltd., and Lucid Group, Inc. during specified periods to join securities class action lawsuits. The lawsuits allege that these companies made false or misleading statements regarding financial guidance and business performance. Investors with losses exceeding $100,000 are encouraged to secure counsel before the August 17, 2026 lead plaintiff deadline.

07/13/2026, 4:48 PM • GlobeNewswire

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Embecta Corp. faces a securities fraud class action lawsuit after revealing a 14% revenue decline due to weakness in pen needle sales and lowering fiscal 2026 guidance on May 5, 2026. The stock plummeted 57.8% to $3.90 per share. Defendants are accused of making materially false statements and failing to disclose material adverse facts about the company's business and prospects during the Class Period (November 25, 2025 - May 4, 2026). The deadline to file a lead plaintiff motion is August 17, 2026.

07/13/2026, 1:33 PM • GlobeNewswire

EMBC SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

A securities class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements about its financial guidance. Embecta's stock plummeted 57.8% on May 5, 2026, after the company disclosed a revenue decline of over 14% and cut its fiscal year 2026 guidance, primarily due to weakness in pen needle sales. The deadline to seek lead plaintiff status is August 17, 2026.

07/11/2026, 8:33 AM • GlobeNewswire

Embecta Corp. (EMBC) Faces Securities Class Action Over Alleged Concealed Material Risks to Pen Needle Revenue– HBSS

Embecta Corp. (EMBC) faces a securities class action lawsuit for allegedly concealing material risks to its pen needle business. The company provided reassuring guidance in February 2026 but reported a shocking 61% sequential EPS decline in Q2 2026, with pen needle revenues suffering massive declines. The company slashed full-year EPS guidance by 43% and cut its dividend by 93%, prompting investigations into whether management knew about revenue headwinds but failed to disclose them.

07/10/2026, 1:45 PM • GlobeNewswire

DEADLINE ALERT for EMBC, FSLR, GTM, BTU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Embecta Corp., First Solar Inc., ZoomInfo Technologies Inc., and Peabody Energy Corporation. The lawsuits allege that defendants made false or misleading statements regarding business guidance, operational performance, and market conditions. Investors have until mid-to-late August 2026 to file lead plaintiff motions.

07/10/2026, 1:00 PM • GlobeNewswire

Embecta (NASDAQ:EMBC) Insulin Pen Issues Trigger Securities Fraud Class Action – Investors Notified to Contact BFA Law about the Lawsuit

A securities fraud class action lawsuit has been filed against Embecta Corp. (NASDAQ:EMBC) after its stock plummeted 57.8% on May 5, 2026. The company allegedly misled investors about the strength of its insulin pen needle product portfolio, claiming resilience while facing significant competition and market softness. The disappointing Q2 2026 results revealed share loss in the pen needle category and led to a dividend reduction from $0.15 to $0.01 per share.

07/10/2026, 6:18 AM • GlobeNewswire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm announces a securities class action lawsuit against Embecta Corp., alleging the company made false and misleading statements about its fiscal results and pen needle business guidance. Investors who purchased EMBC stock between November 25, 2025 and May 4, 2026 may be entitled to compensation. The deadline to serve as lead plaintiff is August 17, 2026.

07/07/2026, 6:30 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Embecta Corp. alleging that the company made materially false and misleading statements about its business and guidance during the period from November 25, 2025 to May 4, 2026. The complaint claims Embecta's pen needle business guidance was unattainable, and the company subsequently missed Q2 2026 expectations with a 14% revenue decline and lowered full-year guidance.

07/07/2026, 12:00 PM • GlobeNewswire

Embecta Corp. (EMBC) Faces Securities Class Action Over Alleged Concealed Material Risks to Pen Needle Revenue – HBSS

Embecta Corp. (EMBC) faces a securities class action lawsuit for allegedly concealing material risks to its pen needle business. The company provided reassuring guidance in February 2026 but reported a shocking 61% sequential EPS decline in Q2 2026, with pen needle revenues suffering massive declines. The company slashed its 2026 EPS guidance by 43% and cut its dividend by 93%, triggering significant shareholder losses.

07/06/2026, 5:20 PM • GlobeNewswire

EMBC CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

Faruqi & Faruqi, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements about its pen needle business and financial guidance. On May 5, 2026, Embecta disclosed a revenue decline of over 14% versus guided flat to 2% decline, causing the stock to plummet 57.8% in a single day. Investors who purchased Embecta securities between November 25, 2025 and May 4, 2026 may be eligible to participate in the lawsuit, with the lead plaintiff deadline set for August 17, 2026.

07/05/2026, 9:26 AM • GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm is soliciting investors who purchased shares of Embecta Corp. (EMBC), Zillow Group (ZG), and Barclays PLC (BCS) during specified periods to join securities class action lawsuits. The firm alleges that Embecta made false statements about its fiscal results and pen needle business guidance before missing expectations and cutting guidance. The lead plaintiff deadline for Embecta is August 17, 2026.

07/04/2026, 7:01 AM • GlobeNewswire

Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

Embecta Corp. (EMBC) faces a securities class action lawsuit for allegedly misleading investors about the stability of its pen needle business. The company provided optimistic guidance in February 2026 but reported a 61% sequential EPS decline in Q2 2026, slashed full-year guidance by 43%, and cut its dividend by 93%, triggering a significant stock selloff. Investors are urged to report losses by August 17, 2026.

07/03/2026, 2:22 PM • GlobeNewswire

DEADLINE ALERT for EMBC, BRCB, and FSLR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Class action lawsuits have been filed against Embecta Corp., Black Rock Coffee Bar, Inc., and First Solar, Inc. for allegedly making materially false statements and failing to disclose material adverse facts. Embecta faces allegations of misleading guidance and U.S. pen needle market weakness. Black Rock Coffee is accused of overstating expansion strategy and experiencing sales cannibalization. First Solar is alleged to have overstated its ability to manage U.S. tariff impacts. Lead plaintiff deadlines range from August 17-24, 2026.

07/02/2026, 1:00 PM • GlobeNewswire

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

Rosen Law Firm has filed a class action lawsuit against Embecta Corp. on behalf of investors who purchased common stock between November 25, 2025 and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before subsequently missing expectations and cutting 2026 fiscal guidance. Investors who purchased shares during this period may be entitled to compensation. The deadline to serve as lead plaintiff is August 17, 2026.

07/01/2026, 9:43 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Embecta Corp. alleging that company executives made materially false and misleading statements about business operations and guidance during the Class Period (November 25, 2025 - May 4, 2026). The complaint claims Embecta misrepresented its pen needle business as 'incredibly resolute' before missing Q2 2026 guidance and cutting full-year guidance, with revenue declining over 14% versus guidance of flat to 2% decline.

06/30/2026, 12:00 PM • GlobeNewswire